Replies to post #338287 on NorthWest Biotherapeutics Inc (NWBO)

[abeta]

notbrad

I think it is -

If been looking in the wrong POT.

This is between UCLA and Merck Sharp & Dohme Corp.

(they would have their own iteration of DCVax)

UCLA / Jonsson Comprehensive Cancer Center Recruiting
Los Angeles, California, United States, 90095
Contact: Stacey Green 310-825-5321 [e-mail]
Contact: Sichen Li 626 921-4291 [e-mail]
Principal Investigator: Timothy F. Cloughesy

The take away line from what you posted is ........

Giving pembrolizumab and ATL-DC vaccine may work better in treating patients with glioblastoma compared to ATL-DC alone.

(I guess "recurrent" is implied but not sure - could be any gbm)

There are 40 patients in the trial and it started in 2019.

Not sure how long it takes to ramp up 40 people. (1 Year ?)

Thank you very much for posting this.

regards